Loading…
Based on limited metadata available, Medaus, Inc. received an FDA Warning Letter on March 8, 2018, regarding products classified as "Other" (specific product type not detailed in available information). Without access to the full letter text or subject line, the exact nature of the violations cannot be determined from this metadata alone. The warning was issued by the FDA, though the specific issuing office is not indicated in the available information. To understand the regulatory concerns and required corrective actions, review of the complete Warning Letter would be necessary.